Towards a more effective and efficient governance and regulation of nanomaterials
© The Author(s). 2017
Received: 17 November 2017
Accepted: 5 December 2017
Published: 19 December 2017
The uncertainty regarding the effects and risks of nanomaterials on human health and the environment, and how they should be tested and assessed in the context of current regulations, is clearly holding back the full exploitation of the innovative potential of nanomaterials. To reduce this uncertainty, the European Union funded NANoREG and ProSafe projects (jointly referred to as N1P) have made a critical evaluation of methods to test and assess these risks in the context of the current registration, evaluation, authorisation and restriction of chemicals (REACH) regulation. Where essential methods were lacking, new ones have been developed. For several existing methods, adjustments have been proposed. Possible improvements to the REACH regulation have also been identified in these projects. The results of N1P have been translated into recommendations for (European) policy makers and regulators. Part of them have a “no regret” character, meaning that the proposed actions can be considered as necessary, feasible, effective and cost efficient. The recommended measures proposed for data quality and data management will create a more solid information basis for risk assessment of nanomaterials. When implemented, the recommendations regarding REACH will improve the application of REACH in both a legal and scientific sense. In practical terms however, the application of REACH will remain complex, time-consuming and costly. Besides that, adapting and specifying the information requirements and test methods in REACH for nanomaterials that are now on the market, will not solve the regulatory hurdles for next generation (nano) materials. To better align the dynamic character of developing new materials and the static character of regulations, it is recommended to explore possibilities of a more future proof approach for securing the safety of new (nano) materials.
The main reason for this rather disappointing conclusion is that the research was predominantly “science-oriented” and not “regulatory-oriented”. Science-oriented research often results in experimental data that cannot be used in a regulatory context where data have to be well defined, standardised, reliable, reproducible and exchangeable. In this context it is important to note that not all traditional, standardised test methods are fit or relevant for nanomaterials. Additionally, methods specifically designed or adapted for testing nanomaterials are sometimes missing or not yet fully evaluated and harmonised.
A complicating factor why research in the past has not led to unambiguous results is the fact that the potential risks of nanomaterials may vary strongly during their life cycle, as a result of the nanomaterial undergoing major transformations. The hazard potential of pristine nanomaterials created during the production process differs from the effects of e.g. nanomaterials embedded in a coating or nanomaterials absorbed onto organic material in an aquatic environment. The presence of (sometimes high levels of) unintentionally produced nanomaterials (caused for example by abrasion or combustion processes) and naturally occurring nanomaterials (caused for example by volcanoes, rock weathering, etc.) further complicates both the distinction and judgement of exposure-related effects linked exclusively to manufactured nanomaterials. On top of this, a variety of analytical problems linked to aggregation, agglomeration and precipitation of nanomaterials in test media can lead to erratic or non-reproducible results.
Equally important, experience shows that the current legislation is not sufficiently robust to assess the risks of nanomaterials in an efficient and effective way. The absence of a robust, legal definition of nanomaterials in REACH leads to disputes as to whether specific information should be provided or not. The entry point for the REACH legislation (chemical identity) currently does not sufficiently cover the specific character of nanomaterials for which size, shape, coating and functionality are dominant factors determining hazard properties. Issues mentioned before like the absence of standardized test methods, and differences in hazard potential during the life cycle of nanomaterials lead to the current situation where it is impossible to come to unambiguous conclusions regarding the risk of most of the nanomaterials in a regulatory context.
N1P has developed recommendations for policy makers and regulators to solve or work around the problems and limitations mentioned above. This led to a White Paper entitled “To a more effective and efficient governance and regulation of nanomaterials”  for which the recommendations are summarized in this paper.
Improving data quality and data management
In order to establish correlations between nanomaterial properties and the key interactions or endpoints in humans and the environment, sufficient well-defined experimental data on environmental, health and safety effects of nanomaterials (nanoEHS) are needed. Such data can serve as the basis for Quantitative Structure-Activity Relationships (QSARs), models, Adverse Outcome Pathways (AOPs) and read-across. These methods and tools can make risk assessment less time consuming and less costly, and are essential for implementing Safe by Design practises. Since reliable test methods have now been developed, it is time to generate these experimental data.
There is a need for demand-driven projects to generate experimental nanoEHS data. Such projects should include adequately characterized materials that have different properties and include appropriate assays for examining interactions or endpoints. Materials that should be included in such a project are (a) “real-world” materials, (b) well-characterized reference materials of varied size, shape, aspect ratio, surface charge, and surface functionality and (c) standard materials for calibrating various assays and measurement tools.
Funding bodies should introduce and enforce an obligation to share the results of nanosafety research as a condition for funding project partners. The obligation should include uploading experimental nanoEHS data in a standardised (ISA-TAB-Nano logic, [3, 4]) way. A valid exemption to this rule would be nanosafety information generated for or by industry with a clearly competitive character.
There is a need for allocating resources for the development and maintenance of a sustainable system for advanced nanoEHS data management, including providing or organising structural funding. Such an advanced system should include the further development and management of ontology, data entry provisions, facilities for storing and querying data, and providing a check on data quality (data curation). This last should be aimed at avoiding or repairing reporting errors as well as judging the regulatory appropriateness of experimental data.
Where possible, calls for nanosafety projects should be far more specific in giving clear instructions to ensure that data and results generated are of a type and form which allows their use in topics of regulatory relevance, such as choice of materials, test methods to be applied, SOPs and data management.
Harmonised occupational exposure limits
Bearing in mind that many nano-innovators are small and medium enterprises (SMEs), as are their downstream users, the most effective and efficient way to manage occupational exposure is by establishing Occupational Exposure Limits (OELs). Several EU Member States are developing or have developed OELs.
The European Commission (DG-EMPL) should initiate a concerted EU - MS effort in setting occupational exposure levels (OELs) for which standardised methods on how to derive these OELs exist. This should include guidelines for studies to be employed, both for conducting risk assessment determinations as well as for setting OELs.
A realistic REACH for nanomaterials
The European Commission and Member States should include a legal definition of nanomaterials in REACH, and should provide a more robust legal basis for additional nano-specific requirements. REACH Annexes and guidance documents should give clarity on the method(s) that can be applied for determining whether a material meets this definition.
The schemes for substance identification and substance specific profiles, irrespective of whether it is a manufactured nanomaterial or not, should be modified as suggested in NANoREG Deliverable 2.12. The morphological categorisation should be modified and aligned with the already developed (International Organization for Standardization) schemes and the OECD Guidance on grouping. Information on particle size distribution, shape, porosity, and surface chemistry should be added to the information requirements.
Innovation in risk assessment
There is a great discrepancy between the time to market of new (applications of) nanomaterials and the time currently needed for risk assessment to comply with REACH (such as chronic exposure studies). Additionally, the costs of such tests are also high. Both constraints can be partially reduced by creating a more fundamental understanding of the mechanisms causing adverse effects (Mode of Action (MoA); AOPs). This makes it possible to predict the effect of nanomaterials on the basis of a more limited set of toxicity data.
It is recommended initiating a project aimed at determining the MoA and AOPs for a number of nanomaterials that are representative for specific groups of nanomaterials while at the same time reducing the need for animal testing. Such an initiative could benefit from the experience of the SEURAT-1 Project  for nanomaterials in cosmetics that was also aimed at achieving a better understanding of mechanisms causing potential adverse effects, while developing methods to reduce animal testing.
Exploring a more future proof approach
To better align the dynamic character of developing new materials and the static character of regulations, the possibilities of a more future proof approach for securing the safety of new (nano)materials must be explored. Some possible options are mentioned in this N1P White Paper  and to some extent have been developed in the NANoREG Framework, such as the “nano-specific risk assessment approach”  and the “safe-by-design approach” [9, 10]. The first option is aligned with a more “concern-based testing approach” based on risk potentials that serve as indicators for potential hazards. It may include the application of functional assays as promising techniques for determining the potential hazard. The safe-by-design approach looks at ways to identify, and thus avoid, possible adverse effects of nanomaterials from the earliest stages of the innovation process onwards.
This paper is compiled from the White Paper . The recommendations are based on the efforts and achievements of a great number of contributors. The almost 90 NANoREG partners from 17 EU Member States and Associated States, Brazil and the Republic of Korea, together with the 11 ProSafe partners provided the scientific and policy related input. The members of the ProSafe Task Force that evaluated over 1000 peer reviewed publications produced the valuable Joint Document that is one of the corner stones of the White Paper. The members of the NANoREG Scientific Advisory Board, together with representatives of Member States and industry, supported both of these projects with critical observations and advice during their set-up and implementation.
Availability of data and materials
The views expressed in this article are those of the author(s) and do not necessarily reflect the views or policies of partners involved in the ProSafe project.
All authors contributed equally. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
All authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- The ProSafe White Paper: Towards a more effective and efficient governance and regulation of nanomaterials. URL: http://www.rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/ProSafe/ProSafe_Deliverables/ProSafe_White_Paper_updated_version_20170922.pdf.
- The NANoREG project – A common European approach to the regulatory testing of Manufactured Nanomaterials. URL: http://www.nanoreg.eu/.
- The ISA-TAB-Nano logic URL: https://wiki.nci.nih.gov/display/ICR/ISA-TAB-Nano.
- The NANoREG Deliverable D1.04, ‘NANoREG data platform operational’, p 12–14 URL: http://rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/NANoREG/deliverables:s_ezJOgJTEaL0lCqO1cAJQ/NANoREG_D1_04_DR_NANoREG_data_platform_operational:BYylp0X-TKGDePFU2oY3_w.org.
- The ProSafe Joint Document URL: http://www.rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/ProSafe/ProSafe_Deliverables/ProSafe_D5_08_Final_report_on_relevant_data_from_NANoREG_and_OECD_WPMN_and_other_projects.pdf.
- The NANoREG Deliverable 2.12, Framework and procedures for characterization and reporting of manufactured nanomaterials for regulatory use. URL: http://rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/NANoREG/deliverables:s_ezJOgJTEaL0lCqO1cAJQ/NANoREG_D2_12_DR_Framework_and_procedures_for_characterization_and_reporting_of_manufactured_nanomaterials_for_regulatory_use.org.
- The Eurat-1 Project: URL: http://www.seurat-1.eu/.Google Scholar
- The NANoREG Deliverable D 5.08, decision tree for risk assessment of MNMs. URL: http://rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/NANoREG/deliverables:s_ezJOgJTEaL0lCqO1cAJQ/NANoREG_D5_08_DR_Decision_tree_for_risk_assessment_of_MNMs.org.
- The NANoREG Safe by Design approach. URL: http://rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/NANoREG/deliverables/20160602_NANoREG_SbD_concept_final.org.
- Park MVDZ, Bleeker EAJ, Brand W, Cassee FR, van Elk M, Gosens I, de Jong WH, Meesters JAJ, Peijnenburg WJGM, Quik JTK, Vandebriel RJ, Sips AJAM. Considerations for safe innovation: the case of Graphene. ACS Nano. 2017;11(10):9574–9593.Google Scholar